Delivery Order SPE2DP23D0001-SPE2D626F202A
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,090.49 to Canadian Commercial Corporation (CCC) on November 6, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with no set-aside designation, with ultimate completion scheduled for January 26, 2026, and performance taking place at CCC's headquarters in Ottawa, Ontario, Canada. As a Crown corporation owned by the Government...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation (CCC) on October 16, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of January 2, 2026. This delivery order carries no set-aside designation and will be performed at CCC's headquarters in Ottawa, Ontario, Canada. CCC, a Crown corporation owned by the Government of Canada, serves as a prime contractor to...
- The U.S. Defense Logistics Agency Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of February 2, 2026. The delivery will be performed at CCC's headquarters in Ottawa, Ontario, Canada. This delivery order carries no set-aside designation, consistent with CCC's status as a foreign government entity and Crown corporation...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $14,633.43 to Canadian Commercial Corporation (CCC) for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order, awarded November 5, 2025, represents a child contract executed against a larger indefinite delivery vehicle. CCC, a Crown corporation owned by the Government of Canada, functions as a government-to-government...
- The Defense Logistics Agency Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with no set-aside designation, reflecting CCC's role as a government-to-government contracting entity rather than a small business concern. The contract is scheduled for completion by February 2, 2026, with performance taking place at CCC's headquarters in...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of February 2, 2026. This delivery order, designated 4570021266, carries no set-aside designation and will be performed at CCC's headquarters in Ottawa, Ontario, Canada. CCC, a Crown corporation of the Government of Canada, serves as a prime...
- The U.S. Defense Logistics Agency Medical Supply Chain division awarded a $1,099.24 delivery order to Canadian Commercial Corporation (CCC) on November 3, 2025, for Inactive Skin Decontamination Lotion (RSDL) 21, with performance completion scheduled for January 21, 2026. The work will be performed in Ottawa, Ontario, Canada. This delivery order carries no set-aside designation, consistent with CCC's status as a Crown corporation of the Government of Canada operating as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a delivery order valued at $2,090.49 to the Canadian Commercial Corporation (CCC) on October 16, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with no set-aside designation, reflecting CCC's status as a government-to-government contracting entity rather than a small business concern. The work is scheduled for completion by January 2, 2026, with...
- This delivery order, awarded on November 5, 2025, to Canadian Commercial Corporation (CCC), a Crown corporation of the Government of Canada, provides for the procurement of Reactive Skin Decontamination Lotion (RSDL) valued at $2,090.49. The contract carries no set-aside designation, consistent with CCC's role as a government-to-government contracting entity. Performance will be completed by January 23, 2026, with work executed at CCC's headquarters in Ottawa, Ontario. The funding agency is...
- This is a $8,361.96 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation of the Canadian government that serves as a prime contractor to U.S. federal agencies. The contract is for the delivery of Reactive Skin Decontamination Lotion (RSDL), a medical supply used for defense purposes. CCC has been awarded multiple indefinite delivery contracts by various U.S. military commands, demonstrating its ability...
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D626F202ADelivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL), with an ultimate completion date of February 2, 2026. This delivery order carries no set-aside designation, consistent with CCC's status as a foreign government entity and Crown corporation owned by the Government of Canada. The work will be performed at CCC's headquarters in Ottawa, Ontario, Canada. This award represents a child contract under a larger Indefinite Delivery Contract framework that enables the Defense Logistics Agency to procure medical supplies and specialized medical equipment from Canadian manufacturers and exporters through government-to-government procurement relationships. CCC serves as a strategic intermediary facilitating U.S. defense procurement from Canadian industrial capabilities across multiple domains including aircraft components, ammunition, mechanical assemblies, and medical supplies. The corporation maintains active Indefinite Delivery Contracts with various U.S. defense agencies valued at tens of millions of dollars, with a demonstrated track record of hundreds of delivery orders and task orders executed in fiscal years 2025-2026 alone. RSDL is a critical chemical decontamination product used by the U.S. military for personnel protection against chemical and biological agents, making this procurement consistent with DLA Medical Supply Chain's mission to support force protection and readiness across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/16/25 |